SCHEMBL786835

SCHEMBL786835

CCOP(=O)(CCCCCCCC[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C)OCC

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.39
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL786990 0.98 PPARD (0.40) PPARDTSHR
SCHEMBL786917 0.91 PPARD (0.35) PPARDTSHR
SCHEMBL15761476 0.81 PPARD (0.39) PPARDTSHR
SCHEMBL14877773 0.81
SCHEMBL11514496 0.76 PPARD (0.61) PPARDTSHR
SCHEMBL11323349 0.76 PPARD (0.61) PPARDTSHR
SCHEMBL7268183 0.76 PPARD (0.61) PPARDTSHR
SCHEMBL21835638 0.75 TSHR (0.35) TSHR
SCHEMBL21835666 0.75 TSHR (0.35) TSHR
SCHEMBL21835664 0.75 TSHR (0.35) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166342-A1 Functionalized Matrices for Dispersion of Nanostructures NANOSYS, INC. (US) 2015-06-18 US disclosed
US-8425803-B2 Nanocrystal doped matrixes SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-04-23 US disclosed
US-20130043433-A1 Functionalized Matrixes for Dispersion of Nanostructures NANOSYS, INC. (US) 2013-02-21 US disclosed
US-8283412-B2 Functionalized matrices for dispersion of nanostructures NANOSYS, INC. (US) 2012-10-09 US disclosed
US-20120068118-A1 NANOCRYSTAL DOPED MATRIXES SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-03-22 US disclosed
US-20100276638-A1 Functionalized matrixes for dispersion of nanostructures NANOSYS, INC. (US) 2010-11-04 US disclosed
US-20100140551-A1 Nanocrystal doped matrixes NANOSYS, INC. (US) 2010-06-10 US disclosed
US-7645397-B2 Luminescent nanocomposite of luminescent nanocrystalline embedded in an epoxy, polyurea, or polyurethane matrix; retain luminescence; surfaces of nanocrystals having bound ligands comprising dicarboxylic acid moiety or aliphatic or polymeric amines; high efficiency solid-state white lighting; optics NANOSYS, INC. (US) 2010-01-12 US disclosed
US-20070034833-A1 Luminescent nanocomposite of luminescent nanocrystalline embedded in an epoxy, polyurea, or polyurethane matrix; retain luminescence; surfaces of nanocrystals having bound ligands comprising dicarboxylic acid moiety or aliphatic or polymeric amines; high efficiency solid-state white lighting; optics NANOSYS, INC. 2007-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100276638-A1 Functionalized matrixes for dispersion of nanostructures STRA6, EPHA6, MIF PPARD 4518/4885TSHR 4031/4885
US-20120068118-A1 NANOCRYSTAL DOPED MATRIXES STRA6, EPHA6, PIR PPARD 4655/4885TSHR 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.